Liaoning Xinde New Material Technology Co (301349) Fair Value & Analysis
Basic Materials · CN · Market cap 8.7B CNY
Fair value as of: Jul 9, 2026
From 15 valuation models · updated today
Fair value updated Jul 9, 2026 — revised from ¥4.61 to ¥31.33 (+579.6%) since Jun 24, 2026. Share price +1.4% over the past month.
Price vs Fair Value (12 months)
12‑month range ¥22.07 – ¥75.60 · fair‑value band ¥23.52 – ¥39.15 · the ¥58.05 price screens above the ¥31.33 fair value. As of Jul 9, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Liaoning Xinde New Material Technology Co (301349) currently trades at ¥58.05, while our model-based Fair Value estimate is ¥31.33 — implying the stock looks roughly 46.0% overvalued today. We read business quality at 54/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Liaoning Xinde New Material Technology Co generated revenue of 1.3B CNY at a net margin of 4.9%. Revenue grew 48.7% year over year. It earns a return on equity of 2.6%. Net debt stands at 137M CNY. Fundamentals as of Jul 9, 2026
Our scenario range runs from ¥23.52 (bear case) to ¥39.15 (bull case); at ¥58.05, the current price sits above that range. The share trades about 16% below its 52-week high and 164% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -59% fair-value upside — at -46%, 301349 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 9, 2026. TTM = trailing twelve months.
About the company
Liaoning Xinde New Material Technology Co., Ltd. engages in the research and development, production, and sale of negative electrode coating materials for lithium-ion batteries in China and internationally. It offers carbon fiber spinnable pitch, lithium-ion battery anode material, and pitch-based carbon fiber products. The company was founded in 2000 and is headquartered in Liaoyang, China.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Liaoning Xinde New Material Technology Co reported revenue of ¥1.2B in FY2025 versus ¥492M in FY2021, a compound +23.9%/yr. Reported net income was ¥38.6M in FY2025, compounding −27.2%/yr from FY2021.
Is 301349 fairly valued? → Check now
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $516.71 | $221.55 | -57% |
| L'Air Liquide S.A AIQUY | $37.81 | $15.56 | -59% |
| Air Products and Chemicals, Inc A1PD34 | R$360.05 | R$108.63 | -70% |
| Intercontinental Exchange, Inc I1CE34 | R$334.47 | R$67.12 | -80% |
| Wanhua Chemical Group 600309 | ¥74.30 | ¥68.03 | -8% |
| Asian Paints Limited ASIANPAINT | ₹2,715 | ₹655.71 | -76% |
| Nan Ya Plastics Corporation 1303 | 154.50 TWD | 7.80 TWD | -95% |
| PPG Industries, Inc PPG | 1,988 MXN | 1,169 MXN | -41% |
| LyondellBasell Industries N.V L1YB34 | R$171.50 | R$203.59 | +19% |
| Solar Industries India Limited SOLARINDS | ₹18,441 | ₹4,083 | -78% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Liaoning Xinde New Material Technology Co (301349) undervalued?
What is the fair value of 301349?
What is the quality score of 301349?
What is the revenue of Liaoning Xinde New Material Technology Co (301349)?
What is the net profit margin of 301349?
Does Liaoning Xinde New Material Technology Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.